These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 18991824)

  • 21. [Antiischemic and metabolic effects of nebivolol and metaprolol CR/XL (betalok ZOK) in patients with postinfarction heart dysfunction].
    Tepliakov AT; Kuznetsova AV; Stepacheva TA; D'iakova ML; Shilov SN; Bolotskaia LA
    Klin Med (Mosk); 2005; 83(4):56-9. PubMed ID: 15941146
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Beta-blockers for heart failure: why you should use them more.
    Ong HT; Kow FP
    J Fam Pract; 2011 Aug; 60(8):472-7. PubMed ID: 21814642
    [No Abstract]   [Full Text] [Related]  

  • 23. A pharmacokinetic and pharmacodynamic comparison of immediate-release metoprolol and extended-release metoprolol CR/XL in patients with suspected acute myocardial infarction: a randomized, open-label study.
    Karlson BW; Dellborg M; Gullestad L; Aberg J; Sugg J; Herlitz J
    Cardiology; 2014; 127(2):73-82. PubMed ID: 24247812
    [TBL] [Abstract][Full Text] [Related]  

  • 24. COMET: a proposed mechanism of action to explain the results and concerns about dose.
    Wikstrand J; Fagerberg B; Goldstein S; Kjekshus J; Wedel H
    Lancet; 2003 Sep; 362(9389):1076-7; author reply 1077-8. PubMed ID: 14522542
    [No Abstract]   [Full Text] [Related]  

  • 25. [Does the use of metoprolol-succinate in patients with chronic heart failure lead to a higher efficacy in treatment without causing additional costs?].
    Sonntag F; Schöffski O; Hass B
    MMW Fortschr Med; 2005 Jun; 147(24):39. PubMed ID: 16001533
    [No Abstract]   [Full Text] [Related]  

  • 26. [Use of metoprolol CR/ZOK in the cardiological practice].
    Podzolkov VI; Samoĭlenko VV; Osadchiĭ KK; Strizhakov LA
    Ter Arkh; 2000; 72(9):78-80. PubMed ID: 11076427
    [No Abstract]   [Full Text] [Related]  

  • 27. Economic implications of extended-release metoprolol succinate for heart failure in the MERIT-HF trial: a US perspective of the MERIT-HF trial.
    Caro JJ; Migliaccio-Walle K; O'Brien JA; Nova W; Kim J; Hauch O; Hillson E; Wedel H; Hjalmarson A; Gottlieb S; Deedwania PC; Wikstrand J;
    J Card Fail; 2005 Dec; 11(9):647-56. PubMed ID: 16360958
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Controlled release metoprolol succinate in MERIT-HF. Analysis of patients subgroups].
    Sidorenko BA; Bugrimova MA; Iosava IK; Pataraia SA; Preobrazhenskiĭ DV
    Kardiologiia; 2008; 48(3):85-8. PubMed ID: 18429761
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Which beta-blocker for heart failure?
    Patel MR; Gattis W
    Am Heart J; 2004 Feb; 147(2):238. PubMed ID: 14760319
    [No Abstract]   [Full Text] [Related]  

  • 30. [Beta-blocking agents in the perioperative period of the non-cardiac surgery].
    Cartoafa M; Agustí MA
    Med Clin (Barc); 2010 Apr; 134(12):544-6. PubMed ID: 20060139
    [No Abstract]   [Full Text] [Related]  

  • 31. Effects of extended-release metoprolol succinate in patients undergoing non-cardiac surgery (POISE trial): a randomised controlled trial.
    ; Devereaux PJ; Yang H; Yusuf S; Guyatt G; Leslie K; Villar JC; Xavier D; Chrolavicius S; Greenspan L; Pogue J; Pais P; Liu L; Xu S; Málaga G; Avezum A; Chan M; Montori VM; Jacka M; Choi P
    Lancet; 2008 May; 371(9627):1839-47. PubMed ID: 18479744
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of beta blockers (carvedilol or metoprolol XL) in patients with transposition of great arteries and dysfunction of the systemic right ventricle.
    Doughan AR; McConnell ME; Book WM
    Am J Cardiol; 2007 Mar; 99(5):704-6. PubMed ID: 17317376
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Beta-blockade for mitral regurgitation: could the management of valvular heart disease actually be moving into the 21st century?
    Carabello BA
    J Am Coll Cardiol; 2012 Aug; 60(9):839-40. PubMed ID: 22818062
    [No Abstract]   [Full Text] [Related]  

  • 34. Ivabradine in combination with metoprolol succinate in the treatment of inappropriate sinus tachycardia.
    Ptaszynski P; Kaczmarek K; Ruta J; Klingenheben T; Cygankiewicz I; Wranicz JK
    J Cardiovasc Pharmacol Ther; 2013 Jul; 18(4):338-44. PubMed ID: 23426376
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Commentary on the Carvedilol or Metoprolol European Trial (COMET).
    Poole-Wilson PA
    Am J Cardiol; 2004 May; 93(9A):40B-2B. PubMed ID: 15144936
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Metoprolol in the treatment of essential hypertension].
    Minushkina LO; Sidorenko BA
    Kardiologiia; 2003; 43(11):102-5. PubMed ID: 14671567
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association of treatment with carvedilol vs metoprolol succinate and mortality in patients with heart failure.
    Pasternak B; Svanström H; Melbye M; Hviid A
    JAMA Intern Med; 2014 Oct; 174(10):1597-604. PubMed ID: 25173681
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effects of combined versus selective adrenergic blockade on left ventricular and systemic hemodynamics, myocardial substrate preference, and regional perfusion in conscious dogs with dilated cardiomyopathy.
    Nikolaidis LA; Poornima I; Parikh P; Magovern M; Shen YT; Shannon RP
    J Am Coll Cardiol; 2006 May; 47(9):1871-81. PubMed ID: 16682315
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The place of metoprolol in the treatment of ischemic heart disease].
    Tereshchenko SN; Kositsyna IV; Dzhaiani NA
    Kardiologiia; 2005; 45(4):98-101. PubMed ID: 15940205
    [No Abstract]   [Full Text] [Related]  

  • 40. Achieving ventricular rate control using metoprolol in β-blocker-naive patients vs patients on chronic β-blocker therapy.
    Kuang P; Mah ND; Barton CA; Miura AJ; Tanas LR; Ran R
    Am J Emerg Med; 2016 Mar; 34(3):606-8. PubMed ID: 26830391
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.